Publication

Article

Supplements and Featured Publications

Inhaled Treprostinil in Pulmonary Hypertension Due to Interstitial Lung Disease
Volume

Inhaled Treprostinil in Pulmonary Hypertension Due to Interstitial Lung Disease

This publication was funded and developed by United Therapeutics.

This AJMC® Clinical Brief summarizes results of the pivotal study by Aaron Waxman MD, PhD, et al published in The New England Journal of Medicine on the safety and efficacy of inhaled treprostinil in patients with pulmonary hypertension due to interstitial lung disease.

Newsletter

Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.

AJMC Managed Markets Network Logo
CH LogoCenter for Biosimilars Logo